... The Italian group also performed a similar study with 90Y-labeled BC-2 and BC-4 mAbs (Riva et al., 2000). Forty-three patients (35 GBM , 6 AA, 2 O) were evaluated including 16 (37%) with small or undetected residual tumor and 19 (44%) with larger lesions. ...
CITATION STYLE
Ayriss, J. E., Kuan, C.-T., Boulton, S. T., Reardon, D. A., & Bigner, D. D. (2009). Molecular Targets for Antibody-Mediated Immunotherapy of Malignant Glioma. In CNS Cancer (pp. 865–898). Humana Press. https://doi.org/10.1007/978-1-60327-553-8_36
Mendeley helps you to discover research relevant for your work.